Development, manufacture and supply of its Hailie digital health technologies which address sub-optimal medication use and improve health outcomes in chronic disease.
Data last updated:May 8, 2024 – 4.10pm. Data is 20 mins delayed.
Previous Close | 0.017 |
|---|---|
Open | 0.016 |
Day Range | 0.016 - 0.018 |
52 Week Range | 0.016 - 0.089 |
Volume | 1,880,288 |
Value | 31,417 |
Bid | 0.016 |
|---|---|
Ask | 0.018 |
Dividend Yield | 0.00% |
P/E Ratio | 0.00 |
Market Cap | 6.631M |
Total Issue | 390,039,981 |
Entitlement Offer Opens and Letters to Shareholders
Non-Renounceable Issue, Letter to Shareholders
Application for quotation of securities - ADR
Appendix 2A (Application for Quotation of Securities)
No stories for Adherium Limited are available.
Search afr.com for Adherium Limited storiesCopyright © 2024. Company information displayed on The Australian Financial Review is sourced from Morningstar and ASX and is subject to their terms and conditions as set out in our Terms of Use. The Australian Financial Review does not accept any responsibility for the accuracy and/or completeness of such data or information.
Sponsored
by Sydney Children’s Hospitals Foundation
Sponsored
by Future Fund
